Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.

William R LumryKarsten WellerMarkus MagerlAleena BanerjiHilary J LonghurstMarc A RiedlHannah B LewisPeng LuGiovanna DevercelliGagan JainMarcus Maurernull null

Published in: Allergy (2020)

Patients with HAE-1/2 experienced significant and clinically meaningful improvements in HRQoL measured by AE-QoL following lanadelumab treatment in the HELP Study.

Keyphrases

replacement therapy